AI.NYSEC3ai, INC

Form 4: Condoleezza Rice Exercises Options, Gains New C3.ai Stock

Sentiment:

Insider Transaction Report


C3.ai Director Condoleezza Rice exercised stock options and received a new grant of options, increasing her beneficial ownership.

Summary

  • Condoleezza Rice, a director of C3.ai, Inc., exercised stock options on October 3, 2025.
  • She acquired 312 shares of Class A Common Stock at an exercise price of $1.86 per share.
  • Following this transaction, her direct beneficial ownership of Class A Common Stock is 74,699 shares.
  • She also indirectly owns 587 shares through the Condoleezza Rice Trust Agreement.
  • Additionally, she was granted 28,628 new stock options with an exercise price of $19.16 per share, expiring on October 2, 2035.
  • These new options will vest quarterly over two years, contingent on her attendance at regularly scheduled board meetings.

Sentiment

Score: 7

Explanation: The transaction reflects a routine compensation event for a director, involving both the exercise of existing options and the grant of new, performance-vesting options. This generally indicates continued alignment of interests with the company's long-term success and does not suggest any immediate positive or negative operational changes.

Positives

  • Director Condoleezza Rice increased her direct beneficial ownership in C3.ai, Inc. by 312 shares, demonstrating continued investment in the company.
  • The grant of 28,628 new stock options aligns the director's incentives with long-term company performance and shareholder value creation.

Risks

  • Vesting of the 28,628 newly granted stock options is contingent on the reporting person remaining a director and attending regularly scheduled board meetings, introducing a performance-based condition to full vesting.

Future Outlook

The new stock option grant, with a 10-year expiration date (October 2, 2035) and a two-year quarterly vesting schedule contingent on board meeting attendance, indicates a long-term incentive structure for the director, aligning her interests with the company's sustained performance.

Industry Context

This Form 4 filing details a routine insider transaction for a director of C3.ai, Inc., a company operating in the artificial intelligence software industry. Director compensation often includes equity grants and options to align the interests of board members with those of shareholders, a common practice across various industries.

Comparison to Industry Standards

  • Director compensation packages, including stock option grants with vesting schedules, are standard practice across publicly traded companies to incentivize long-term commitment and performance.
  • The specific exercise prices and number of shares granted are typically determined by company-specific compensation policies, board discretion, and market conditions at the time of grant, making direct comparisons without detailed peer data difficult.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation StructureGrant of new stock options with performance-based vesting (board meeting attendance) over a two-year period.10/03/2025Aligns director incentives with company performance and long-term value creation, promoting active participation in governance through attendance requirements.

Related Party Transactions

  • The indirect beneficial ownership of 587 shares is held by the Condoleezza Rice Trust Agreement U/A/D 11/24/99, of which the Reporting Person is trustee, constituting a related party transaction.

Stakeholder Impact

  • Shareholders: The transaction demonstrates continued director engagement and aligns a key director's financial interests with the long-term performance of the company.
  • Employees: No direct impact on employees is indicated by this insider transaction report.

Next Steps

  • Condoleezza Rice will continue to serve as a director of C3.ai, Inc.
  • The newly granted stock options will vest quarterly over the next two years, contingent on her attendance at board meetings, with potential for suspended shares to vest later if attendance requirements are met.

Key Dates

DateDescription
11/24/1999Date of the Condoleezza Rice Trust Agreement U/A/D, which holds indirect beneficial ownership.
10/03/2025Date of earliest transaction, including the exercise of stock options and the grant of new stock options.
10/07/2025Signature date of the reporting person's attorney-in-fact for the filing.
11/29/2026Expiration date for the stock options that were exercised.
10/02/2035Expiration date for the newly granted stock options.

Recommendation

hold

This Form 4 filing details a routine insider transaction where a director exercised existing options and received a new grant. While it shows continued director engagement and alignment, it does not present new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It's a standard compensation event that does not alter the underlying investment thesis.

Keywords

C3.ai, AI, Condoleezza Rice, Form 4, insider transaction, stock options, director compensation, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.